)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
SCYNEXIS
SCYNEXIS (SCYX) investor relations material
SCYNEXIS Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary1 May, 2026
Company overview and business model
Clinical-stage biotech focused on severe rare diseases, notably ADPKD and antifungal therapies.
Lead assets include SCY-770 (for ADPKD, Orphan Drug Designation) and SCY-247 (antifungal, Fast Track and Orphan Drug status).
Commercial rights to ibrexafungerp (BREXAFEMME) licensed to GSK; SCY-247 and other compounds retained.
Financial performance and metrics
Limited history of profitability; only one product approved and licensed out.
Generated limited revenue from product sales to date.
Use of proceeds and capital allocation
No proceeds from resale of shares by selling stockholders; proceeds only from cash exercise of warrants.
Company bears registration costs; selling stockholders pay their own selling expenses.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SCYNEXIS
- Key votes include board elections, auditor ratification, and major share authorization changes.SCYX
Proxy filing1 May 2026 - Annual meeting seeks approval for director elections, equity plan expansion, and capital increase.SCYXProxy filing30 Apr 2026
- Shareholders will vote on a reverse stock split to help maintain Nasdaq listing compliance.SCYXProxy filing27 Apr 2026
- Shareholders will vote on director elections, compensation, equity plan, and capital structure changes.SCYXProxy filing20 Apr 2026
- Shareholders will vote on a reverse stock split to help maintain Nasdaq listing compliance.SCYXProxy filing17 Apr 2026
- Acquisition of SCY-770 for ADPKD offers major commercial potential and no royalty obligations.SCYXM&A announcement2 Apr 2026
- SCY-247 advances as a potent antifungal with strong clinical data and significant market potential.SCYXinvestor presentation4 Mar 2026
- 2025 revenue rose sharply on GSK deals; SCY-247 clinical progress and cash runway extended.SCYXQ4 20254 Mar 2026
- Advancing next-gen antifungal SCY-247 and expanding GSK partnership, with strong financials.SCYXH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
Next SCYNEXIS earnings date
Q1 202613 May, 2026
SCYNEXIS
Next SCYNEXIS earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage